caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1225390446

Babak HosseiniO.D.

OptometryBethesda, MDI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
QUALITY · MIPS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
137
Beneficiaries
—
Total drug cost
$107K
Distinct drugs
5
Brand share
67.9%
Top prescribed drugs
Neomycin/Polymyxin B/Dexametha36 claims
Cyclosporine32 claims
Lifitegrast25 claims
Cyclosporine19 claims
Latanoprost13 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$447
Payment records
20
By payment type
Food and Beverage$447
REFERRAL NETWORK

Where Babak Hosseini's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 0 inbound referrers · 2 outbound destinations.

Receives referrals from
Inbound — who sends patients here
No inbound pairs above the suppression threshold.
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
Jesus Martinez
Ophthalmology · Rockville, MD
1214
Laboratory Corporation Of America Holdings
Clinical Laboratory · Burlington, NC
1119
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
508
Unique beneficiaries
—
Total services
566
Distinct HCPCS
10
Medicare payment
$31K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 449 Optometry providers in MD — above median (cohort median 277).